Netherlands· NL-e6f449245bf9
Xenical, capsules 120 mg
A orlistat product containing orlistat, registered in Netherlands by CHEPLAPHARM Arzneimittel GmbH. The same ATC class is registered in 16 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Orlistat is registered in 16 of 19 countries.
Countries holding a registration under ATC A08AB01 (orlistat), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 9 of them publish a price we can compare per daily dose
Orlistat · ATC A08AB01
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of orlistat costs, country by country.
Normalised to the WHO defined daily dose (0.36 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Orlistat · price per daily dose (0.36 g)
USD · FX 28 Sept 2026
- CH Switzerland$3.08
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- ORLISTAT
- Manufacturer
- CHEPLAPHARM Arzneimittel GmbH
- Country
- Netherlands (NL)
- ATC code
- A08AB01
- ATC class
- Orlistat
- Defined daily dose
- 0.36 g, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/98/071
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
374 interactions on record for orlistat.
Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Orlistat · interactions on record
374 records
- 9 severe
- 117 moderate
- 8 minor
- 238 info
Most severe, free to view
- TriheptanoinA16AX17severe
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- PexidartinibL01EX15severe
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Orlistat in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainNORMOSTAT 120 MG CAPSULAS DURASLaboratorios Normon S.A.
- United KingdomBeacita 120mg capsulesActavis UK Ltd
- CzechiaORLISTAT SANDOZSandoz s.r.o., Praha
- SwitzerlandOrlistat Sandoz, HartkapselnSandoz Pharmaceuticals AG
- IrelandOrlistat Accord 120 mg hard capsulesAccord Healthcare Ireland Ltd.
- FinlandAlliGlaxo Group Ltd
- SwedenBeacita 120 mg Kapsel, hårdTeva B.V.
- BelgiumOrlistat Sandoz 120 mgSandoz
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Belgium · Orlistat Sandoz, Orlistat Teva
- Czechia · Orlistat 1 A Pharma, Orlistat Sandoz
- Germany · Orlistat 1 A Pharma, Orlistat Hexal
- Denmark · Orlistat Accord, Orlistat Rivopharm
- Estonia · Orlistat Sandoz
- Spain · Beacita, Elimens
- Finland · Orlistat Sandoz, Orlistat Stada
- France · Orlistat Eg
- United Kingdom (Northern Ireland) · Orlistat, Orlistat Accord-Uk
- Ireland · Orlistat Accord
- Iceland · Alli, Xenical
- Italy · Beacita
- Liechtenstein · Alli, Xenical
- Lithuania · Orlistat Polpharma
- Latvia · Orlistat Polpharma
- Norway · Alli, Orlistat Accord
- Portugal · Orlistato Beacita, Orlistato Ciclum
- Sweden · Beacita, Orlistat Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d7236bee-6d21-4725-8319-461468d1f1f1 GET /v1/drugs/d7236bee-6d21-4725-8319-461468d1f1f1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Capsule, hard",
"route": "Oraal gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/xenical-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Orlistat",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp70163",
"excipients": [
"AMMONIA (E 527)",
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"GELATINE (E 441)",
"IJZEROXIDE ZWART (E 172)",
"INDIGOKARMIJN (E 132)",
"KALIUMHYDROXIDE (E 525)",
"NATRIUMLAURILSULFAAT",
"NATRIUMZETMEELGLYCOLAAT",
"POVIDON K 30 (E 1201)",
"PROPYLEENGLYCOL (E 1520)",
"SCHELLAK (E 904)",
"TALK (E 553b)",
"TITAANDIOXIDE (E 171)",
"ZWARTE INKT"
],
"substances": [
"ORLISTAT"
],
"leaflet_url": null,
"authorised_at": "1998/07/29",
"procedure_number": "EMEA/H/C/000154",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/98/071",
"additional_monitoring": "N"
}See everything about orlistat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.